Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139776
Status:
COMPLETED
Last Update Posted:
2021-03-29
First Post:
2005-08-29
Brief Title:
Study Of Continuous Use Of Celecoxib Vs Usual or Intermittent Use
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteoarthritis Hip |
| Osteoarthritis Knee |
Keywords:
| Name | View |
|---|---|
| Chronic treatment osteoarthritis Celecoxib Continuous Use Intermittent Use | View |